Tag Archives: severe aplastic anaemia

GSK submits variation to the Marketing Authorisation for eltrombopag (Revolade™) to the European Medicines Agency (EMA)

LONDON, 13-11-2014 — /EuropaWire/ — GSK today announced the submission to the European Medicines Agency (EMA) of a variation to the Marketing Authorisation for eltrombopag (Revolade™), seeking an additional indication for the treatment of adult patients with severe aplastic anaemia … Read the full press release